Pharmafile Logo
Pharmafocus logo
Advanced Search

St. Jude

Showing 4 posts of 4 posts found.

Abbott issues patch for vulnerable heart devices

August 31, 2017
Medical Communications, Sales and Marketing Abbot, St. Jude, biotech, drugs, pharma, pharmaceutical

A year on from the revelation that digital pacemakers were vulnerable to hackers, Abbott and the FDA has announced that …

News

FDA warns that St. Jude’s heart devices could be hacked

January 11, 2017
Medical Communications, Research and Development Abbott, Muddy waters, St. Jude, medsec

The FDA regulator has publicly announced that there are safety issues with certain of St. Jude’s medical devices, including cardiac …

News
abbottweb_2

Abbott completes $25 billion deal for St. Jude

January 9, 2017
Sales and Marketing Abbott, St. Jude

It has been announced that the Federal Trade Commission has approved Abbott Laboratories acquisition of St. Jude Medical for $25 …

News

Abbott-St. Jude $25 billion deal close to clearance

November 16, 2016
Research and Development, Sales and Marketing Abbott, St. Jude, acquisition

EU antitrust regulators are due to reach a decision on the deal on 23 November that would see Abbott Laboratories …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024